Vimarsana
Biggest News Aggregation in the World

Gorilla Healing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gorilla Healing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gorilla Healing Today - Breaking & Trending Today

FDA Warns Online Vendors to Stop Selling Unapproved Weight-Loss Drugs - Vimarsana News

FDA Warns Online Vendors to Stop Selling Unapproved Weight-Loss Drugs

The FDA on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide.

FDA warns online vendors to stop selling unapproved weight-loss drugs semaglutide and tirzepatide - Vimarsana News

FDA warns online vendors to stop selling unapproved weight-loss drugs semaglutide and tirzepatide

FDA issued warning letters to two online retailers, Semaspace and Gorilla Healing, instructing them to cease selling unapproved versions of semaglutide and tirzepatide

Source: wfin.com
US FDA warns online vendors to stop selling unapproved weight-loss drugs - Vimarsana News

US FDA warns online vendors to stop selling unapproved weight-loss drugs

The U.S. Food and Drug Administration (FDA) on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide, the active ingredients in popular GLP-1 class medications including Novo Nordisk’s powerful weight-loss drug Wegovy. In the letters sent to Semaspace and Gorilla Healing on Oct. 2, the FDA said the only approved semaglutide products were Wegovy and Novo’s diabetes drugs Ozempic and Rybelsus.

Source: yahoo.com
FDA warns online vendors to stop selling unapproved weight-loss drugs semaglutide and tirzepatide - Vimarsana News

FDA warns online vendors to stop selling unapproved weight-loss drugs semaglutide and tirzepatide

FDA issued warning letters to two online retailers, Semaspace and Gorilla Healing, instructing them to cease selling unapproved versions of semaglutide and tirzepatide